Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: a Phase II study.
Morganti AG, Cellini F, Mignogna S, Padula GD, Caravatta L, Deodato F, Picardi V, Macchia G, Cilla S, Buwenge M, Di Lullo L, Gambacorta MA, Balducci M, Mattiucci GC, Autorino R, Valentini V.
Morganti AG, et al. Among authors: di lullo l.
Future Oncol. 2016 Mar;12(6):779-87. doi: 10.2217/fon.15.350. Epub 2016 Feb 1.
Future Oncol. 2016.
PMID: 26829128
Clinical Trial.